Back
Franklin FTSE United Kingdom ETF Vs. Sarepta Therapeutics, Inc. Industry Stock Comparison
Buy
80
FLGB
Franklin FTSE United Kingdom ETF
Last Price:
$33.83
Seasonality Move:
-0.64%
Sell
44
SRPT
Sarepta Therapeutics, Inc.
Last Price:
$22.10
Seasonality Move:
6.08%
Buy
80
Franklin FTSE United Kingdom ETF (FLGB)
is a Buy
Is Franklin FTSE United Kingdom ETF a Buy, Sell or Hold?
-
The current Franklin FTSE United Kingdom ETF [FLGB] share price is $33.88. The Score for FLGB is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
-
FLGB is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Sarepta Therapeutics, Inc. (SRPT)
is a Sell
Is Sarepta Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Sarepta Therapeutics, Inc. [SRPT] share price is $22.12. The Score for SRPT is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FLGB Stock Price Chart
What is Franklin FTSE United Kingdom ETF's stock price today?
-
The Franklin FTSE United Kingdom ETF share price today is $33.88Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FLGB is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics, Inc.'s stock price today?
-
The Sarepta Therapeutics, Inc. share price today is $22.12Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing slight selling pressure.
FLGB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.27 | Buy |
| Relative Strength Index (14 RSI): | 62.55 | Buy |
| Chaikin Money Flow: | 30252 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.53 - 33.63) | Buy |
| Bollinger Bands (100): | (31.75 - 33.09) | Buy |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.95 | Buy |
| Relative Strength Index (14 RSI): | 56.1 | Buy |
| Chaikin Money Flow: | -75967 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.51 - 22.53) | Buy |
| Bollinger Bands (100): | (17.83 - 22.33) | Buy |
FLGB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.6 | Buy |
| 20-day SMA: | 33.31 | Buy |
| 50-day SMA: | 32.91 | Buy |
| 200-day SMA: | 31.06 | Buy |
| 8-day EMA: | 33.59 | Buy |
| 20-day EMA: | 33.32 | Buy |
| 50-day EMA: | 32.46 | Buy |
| 200-day EMA: | 21.04 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.56 | Buy |
| 20-day SMA: | 21.6 | Buy |
| 50-day SMA: | 20.78 | Buy |
| 200-day SMA: | 30.48 | Sell |
| 8-day EMA: | 17.99 | Buy |
| 20-day EMA: | 10.86 | Buy |
| 50-day EMA: | 5.25 | Buy |
| 200-day EMA: | 1.45 | Buy |
Franklin FTSE United Kingdom ETF Earnings Growth & FLGB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics, Inc. Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.54 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.05 per share, and an increase next year of $4.83 per share.
Franklin FTSE United Kingdom ETF Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||